Mutations on the Switch III region and the alpha3 helix of Galpha 16 differentially affect receptor coupling and regulation of downstream effectors
Tóm tắt
Gα16 can activate phospholipase Cβ (PLCβ) directly like Gαq. It also couples to tetratricopeptide repeat 1 (TPR1) which is linked to Ras activation. It is unknown whether PLCβ and TPR1 interact with the same regions on Gα16. Previous studies on Gαq have defined two minimal clusters of amino acids that are essential for the coupling to PLCβ. Cognate residues in Gα16 might also be essential for interacting with PLCβ, and possibly contribute to TPR1 interaction and other signaling events. Alanine mutations were introduced to the two amino acid clusters (246–248 and 259–260) in the switch III region and α3 helix of Gα16. Regulations of PLCβ and STAT3 were partially weakened by each cluster mutant. A mutant harboring mutations at both clusters generally produced stronger suppressions. Activation of Jun N-terminal kinase (JNK) by Gα16 was completely abolished by mutating either clusters. Contrastingly, phosphorylations of extracellular signal-regulated kinase (ERK) and nuclear factor κB (NF-κB) were not significantly affected by these mutations. The interactions between the mutants and PLCβ2 and TPR1 were also reduced in co-immunoprecipitation assays. Coupling between G16 and different categories of receptors was impaired by the mutations, with the effect of switch III mutations being more pronounced than those in the α3 helix. Mutations of both clusters almost completely abolished the receptor coupling and prevent receptor-induced Gβγ release. The integrity of the switch III region and α3 helix of Gα16 is critical for the activation of PLCβ, STAT3, and JNK but not ERK or NF-κB. Binding of Gα16 to PLCβ2 or TPR1 was reduced by the mutations of either cluster. The same region could also differentially affect the effectiveness of receptor coupling to G16. The studied region was shown to bear multiple functionally important roles of G16.
Tài liệu tham khảo
Venkatakrishnan G, Exton JH: Identification of determinants in the alpha-subunit of Gq required for phospholipase C activation. J Biol Chem 1996, 271:5066–5072.
Coleman DE, Berghuis AM, Lee E, Linder ME, Gilman AG, Sprang SR: Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science 1994, 265:1405–1412.
Lambright DG, Noel JP, Hamm HE, Sigler PB: Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. Nature 1994, 369:621–628.
Offermanns S, Simon MI: G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. J Biol Chem 1995, 270:15175–15180.
Wilkie TM, Scherle PA, Strathmann MP, Slepak VZ, Simon MI: Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines. Proc Natl Acad Sci USA 1991, 88:10049–10053.
Shyamala V, Khoja H: Interleukin-8 receptors R1 and R2 activate mitogen-activated protein kinases and induce c-fos, independent of Ras and Raf-1 in Chinese hamster ovary cells. Biochemistry 1998, 37:15918–15924.
Lo RK, Cheung H, Wong YH: Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism. J Biol Chem 2003, 278:52154–52165.
Heasley LE, Storey B, Fanger GR, Butterfield L, Zamarripa J, Blumberg D, Maue RA: GTPase-deficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases. Mol Cell Biol 1996, 16:648–656.
Higashita R, Li L, Van Putten V, Yamamura Y, Zarinetchi F, Heasley L, Nemenoff RA: Galpha16 mimics vasoconstrictor action to induce smooth muscle alpha-actin in vascular smooth muscle cells through a Jun-NH2-terminal kinase-dependent pathway. J Biol Chem 1997, 272:25845–25850.
Lo RK, Wong YH: Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway. Cell Signal 2006, 18:2143–2153.
Liu AM, Wong YH: G16-mediated activation of nuclear factor kappaB by the adenosine A1 receptor involves c-Src, protein kinase C, and ERK signaling. J Biol Chem 2004, 279:53196–53204.
Yang M, Sang H, Rahman A, Wu D, Malik AB, Ye RD: G alpha 16 couples chemoattractant receptors to NF-kappa B activation. J Immunol 2001, 166:6885–6892.
Marty C, Browning DD, Ye RD: Identification of tetratricopeptide repeat 1 as an adaptor protein that interacts with heterotrimeric G proteins and the small GTPase Ras. Mol Cell Biol 2003, 23:3847–3858.
Bae H, Anderson K, Flood LA, Skiba NP, Hamm HE, Graber SG: Molecular determinants of selectivity in 5-hydroxytryptamine1B receptor-G protein interactions. J Biol Chem 1997, 272:32071–32077.
Berlot CH, Bourne HR: Identification of effector-activating residues of Gs alpha. Cell 1992, 68:911–922.
Cai K, Itoh Y, Khorana HG: Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: use of a photoactivatable reagent. Proc Natl Acad Sci USA 2001, 98:4877–4882.
Grishina G, Berlot CH: A surface-exposed region of G(salpha) in which substitutions decrease receptor-mediated activation and increase receptor affinity. Mol Pharmacol 2000, 57:1081–1092.
Ho MK, Wong YH: The amino terminus of Galpha(z) is required for receptor recognition, whereas its alpha4/beta6 loop is essential for inhibition of adenylyl cyclase. Mol Pharmacol 2000, 58:993–1000.
Lee CH, Katz A, Simon MI: Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor. Mol Pharmacol 1995, 47:218–223.
Skiba NP, Bae H, Hamm HE: Mapping of effector binding sites of transducin alpha-subunit using G alpha t/G alpha i1 chimeras. J Biol Chem 1996, 271:413–424.
Ho MK, Yung LY, Wong YH: Disruption of receptor-mediated activation of G protein by mutating a conserved arginine residue in the switch II region of the alpha subunit. J Neurochem 1999, 73:2101–2109.
Ho MK, New DC, Wong YH: Co-expressions of different opioid receptor types differentially modulate their signaling via G(16). Neurosignals 2002, 11:115–122.
Wu EH, Lo RK, Wong YH: Regulation of STAT3 activity by G16-coupled receptors. Biochem Biophys Res Commun 2003, 303:920–925.
Liu AM, Ho MK, Wong CS, Chan JH, Pau AH, Wong YH: Galpha(16/z) chimeras efficiently link a wide range of G protein-coupled receptors to calcium mobilization. J Biomol Screen 2003, 8:39–49.
Federman AD, Conklin BR, Schrader KA, Reed RR, Bourne HR: Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits. Nature 1992, 356:159–161.
Tang WJ, Gilman AG: Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science 1991, 254:1500–1503.
Grishina G, Berlot CH: Mutations at the domain interface of GSalpha impair receptor-mediated activation by altering receptor and guanine nucleotide binding. J Biol Chem 1998, 273:15053–15060.
Shaul YD, Seger R: The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 2007, 1773:1213–1226.
Werry TD, Sexton PM, Christopoulos A: "Ins and outs" of seven-transmembrane receptor signalling to ERK. Trends Endocrinol Metab 2005, 16:26–33.
Jain N, Zhang T, Fong SL, Lim CP, Cao X: Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 1998, 17:3157–3167.
Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R: Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 1999, 19:7519–7528.
Chan AS, Wong YH: Gbetagamma signaling and Ca2+ mobilization co-operate synergistically in a Sos and Rac-dependent manner in the activation of JNK by Gq-coupled receptors. Cell Signal 2004, 16:823–836.
Chan AS, Yeung WW, Wong YH: Integration of G protein signals by extracellular signal-regulated protein kinases in SK-N-MC neuroepithelioma cells. J Neurochem 2005, 94:1457–1470.
Kam AY, Chan AS, Wong YH: Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells. J Pharmacol Exp Ther 2004, 310:301–310.
Kam AY, Chan AS, Wong YH: Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase. J Neurochem 2004, 89:391–402.
Kam AY, Chan AS, Wong YH: Rac and Cdc42-dependent regulation of c-Jun N-terminal kinases by the delta-opioid receptor. J Neurochem 2003, 84:503–513.
Chen BC, Lin WW: PKC- and ERK-dependent activation of I kappa B kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation. Br J Pharmacol 2001, 134:1055–1065.
Ho RC, Hirshman MF, Li Y, Cai D, Farmer JR, Aschenbach WG, Witczak CA, Shoelson SE, Goodyear LJ: Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol 2005, 289:C794–801.
Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH: Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J Biol Chem 2000, 275:19693–19699.
Marsh SR, Grishina G, Wilson PT, Berlot CH: Receptor-mediated activation of Gsalpha: evidence for intramolecular signal transduction. Mol Pharmacol 1998, 53:981–990.
Bakker RA, Casarosa P, Timmerman H, Smit MJ, Leurs R: Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors. J Biol Chem 2004, 279:5152–5161.
Shryock JC, Ozeck MJ, Belardinelli L: Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol Pharmacol 1998, 53:886–893.
Klinger M, Kuhn M, Just H, Stefan E, Palmer T, Freissmuth M, Nanoff C: Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation. Naunyn Schmiedebergs Arch Pharmacol 2002, 366:287–298.
Maenhaut C, Van Sande J, Libert F, Abramowicz M, Parmentier M, Vanderhaegen JJ, Dumont JE, Vassart G, Schiffmann S: RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 1990, 173:1169–1178.
Varani K, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Benini A, Klotz KN, Baraldi PG, Tabrizi MA, Lennan SM, et al.: Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors. Biochem Pharmacol 2005, 70:1601–1612.
Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD: Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003, 31:3497–3500.
Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003, 31:3381–3385.
Wall MA, Coleman DE, Lee E, Iniguez-Lluhi JA, Posner BA, Gilman AG, Sprang SR: The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell 1995, 83:1047–1058.
Lambright DG, Sondek J, Bohm A, Skiba NP, Hamm HE, Sigler PB: The 2.0 A crystal structure of a heterotrimeric G protein. Nature 1996, 379:311–319.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res 2000, 28:235–242.
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE: UCSF Chimera – a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605–1612.
Tsu RC, Chan JS, Wong YH: Regulation of multiple effectors by the cloned delta-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase. J Neurochem 1995, 64:2700–2707.
Wong YH: Gi assays in transfected cells. Methods Enzymol 1994, 238:81–94.
Girish V, Vijayalakshmi A: Affordable image analysis using NIH Image/ImageJ. Indian J Cancer 2004, 41:47.
Chan AS, Wong YH: Regulation of c-Jun N-terminal kinase by the ORL(1) receptor through multiple G proteins. J Pharmacol Exp Ther 2000, 295:1094–1100.